Panomics
Panomics sells a cloud-based multi-omics data analysis platform to biopharma, real-world data aggregators, and academic medical centers. It combines sample management, no-code and code-based analysis, and a data lake for drug repurposing on a single subscription product.
- Company typePrivate
- Founded2022
- HeadquartersNew York, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Panomics does
Panomics is a privately held, New York-based biotechnology software company founded in 2022 and operated by Gene Guard, Inc. (DBA Panomics, Inc.), that sells a cloud-based multi-omics data analysis platform to biopharmaceutical organizations, real-world data aggregators, and academic medical centers. The platform is structured around three modules — Manage for sample ingestion, metadata curation, and library construction; Analyze for interactive visual analysis plus code-based runtimes in JupyterLab and RStudio with on-demand cloud compute; and Discover for data lake exploration, experiment similarity matching, gene co-perturbation analysis, and drug repurposing. It supports transcriptomics (microarray, bulk RNA-seq, scRNA-seq) and proteomics data, processes common formats (CSV, h5, h5ad), exposes API keys for programmatic integration, and offers execution pods that let bioinformaticians deploy custom tools inside the platform. Enterprise-grade features include fine-grained role-based access control with audit logging, encryption, and operation inside customer cloud infrastructure.
The company monetizes via custom quote-based SaaS/PaaS subscriptions with annual billing, structured into three industry solutions (Pharma & Biotech, Real-World Data Aggregators, and Academic Medical Centers). Go-to-market is direct enterprise field sales driven by "Book a demo" CTAs and a structured discovery process; marketing assets include case studies, a self-serve FAQ, and GitBook-hosted technical documentation. Named customers include Champions Oncology and PanCAN, with a published case study in Inflammatory Bowel Disease. Panomics holds EU-U.S. and Swiss-U.S. Data Privacy Framework certifications and operates GDPR-compliant processing for EEA, UK, and Swiss personal data, supporting transatlantic enterprise deployment.
Panomics firmographics
Firmographics- Name
- Panomics
- Legal name
- Panomics, Inc.
- Website
- https://panomics.bio
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Panomics sells a cloud-based multi-omics data analysis platform to biopharma, real-world data aggregators, and academic medical centers. It combines sample management, no-code and code-based analysis, and a data lake for drug repurposing on a single subscription product.
- Ownership category
- akta.pro rank
Panomics industry classification
Industry- Product category
- Bioinformatics / Multi-omics Analysis Software
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Computer Systems Design and Related Services (54151), Medical Laboratories (621511)
- SIC
- Services-Prepackaged Software (7372), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Bioinformatics & Multi-omics Analysis Software (HLAGAJAD)
- akta.pro secondary industries
- Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI), Multi-Omics Precision Medicine Platforms (genomics/proteomics/metabolomics) (HLAAANAF), Genomic Profiling & Sequencing-Based Precision Medicine (HLAAANAA)
Keywords
Where Panomics is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Panomics business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Infrastructure, Personnel, Marketing or Sales, Operations
Revenue model
- SaaS Platform Subscription: Cloud-based SaaS/PaaS platform offering flexible pricing plans based on scale and features required. Subscription model with enterprise pricing tiers tailored to organization size and feature requirements.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Custom enterprise pricing based on organizational scale and feature requirements |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Panomics product offering
Product offeringCore offering
Panomics provides a cloud-based SaaS/PaaS platform for multi-omics data analysis, unifying secure sample management, interactive visual analysis, and a data lake for similarity searches and drug repurposing. The platform supports both no-code point-and-click analysis for biologists and code-based environments (JupyterLab/RStudio) for bioinformaticians, integrating transcriptomics (microarray, bulk RNA-seq, scRNA-seq) and proteomics data with role-based access control and audit logging for enterprise compliance.
Product overview
Panomics is a cloud-based SaaS/PaaS platform for multi-omics data analysis, consisting of three core modules: Manage (for sample ingestion, metadata curation, and library construction), Analyze (interactive visual analysis with customizable computational tools), and Discover (for comparing insights across biological contexts and identifying patterns). The platform supports both codeless analysis via point-and-click interfaces and code-based analysis through JupyterLab or RStudio runtimes. Industry solutions target Pharma & Biotech (drug discovery), Real-World Data Aggregators, and Academic Medical Centers. Key features include OmicsBrowser for data visualization, Gene Signature Similarity for pattern discovery, and execution pods for deploying custom applications.
Differentiator
Problem solved
Functional benefit
Products and services
- Panomics Platform
- Pharma & Biotech Solution
- Real-World Data Aggregators Solution
- Academic Medical Centers Solution
Quantifiable outcome
- Reduces time spent on data management and analysis setup through streamlined workflows and integrated tools
- +2 more outcomes
Companies that use Panomics
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Panomics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature6 records
Panomics partnerships and signals
Strategic signalScale indicators1 record
Recent moves5 records
Expansion highlights4 records
Panomics competitors and assessment
Company assessmentDirect peers
- DNAnexus: DNAnexus provides a cloud-based biomedical data analysis and management platform supporting multi-omics workflows for pharma and clinical customers. It is the closest direct competitor to Panomics, offering secure data management, bioinformatics runtimes, and collaboration tools for enterprise biopharma.
- Lifebit: Lifebit provides a federated genomics and biomedical data platform for pharma and research institutions. It competes with Panomics on cloud-based omics data management, secure collaboration, and enterprise bioinformatics workflows.
- BC Platforms: BC Platforms offers a genomic and clinical data management platform with analytics tools for pharma, biobanks, and healthcare systems. Comparable to Panomics in serving real-world data aggregators and pharma customers with secure, multi-omics-enabled data infrastructure.
- Velsera (Seven Bridges): Velsera (formerly Seven Bridges) operates a bioinformatics and multi-omics analysis platform serving pharma, diagnostics, and research customers. Like Panomics, it combines data management, analysis pipelines, and discovery tools in a cloud environment for enterprise users.
- SOPHiA Genetics: SOPHiA Genetics offers a cloud-based platform for genomics and multi-omics data analysis used by hospitals, labs, and biopharma. It directly overlaps with Panomics in cloud-native analysis, biomarker discovery, and enterprise health/biopharma customer targeting.
Others
- TetraScience: TetraScience provides a cloud-native scientific data platform with a focus on lab data unification across R&D. It is adjacent rather than directly competitive, but its emphasis on enterprise biopharma data infrastructure overlaps thematically with Panomics' data management positioning.
Broad incumbents
- Dotmatics: Dotmatics is an established scientific R&D platform offering broader lab informatics, ELN, and data analysis capabilities across pharma. While much broader than Panomics, it competes in adjacent enterprise biology data management and analytics territory.
- Illumina (Illumina Connected Analytics): Illumina offers cloud-based genomics data management and analytics through ICA, leveraging its dominant sequencing installed base. As a broad incumbent, it competes with Panomics in the multi-omics cloud analysis space with greater scale and instrument integration.
Emerging players
- Genestack: Genestack provides an omics data management and analysis platform for pharma, agritech, and research organizations. It overlaps with Panomics in multi-omics data lake, no-code analysis interfaces, and enterprise biopharma positioning, though at a smaller scale.
- Form Bio: Form Bio (a Veralto spinout) offers a cloud-based bioinformatics and multi-omics analysis platform with collaborative workflows for researchers. It targets similar academic and biopharma users with code-based and visual analysis tools.
Market position
Strengths2 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights5 records
Customer concentration
Panomics compliance and trust
Trust signalCompliance3 records
Panomics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Panomics leadership team
Management profileNumber of profiles
Profiles1 record
Panomics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Panomics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Panomics
What does Panomics do?
Panomics provides a cloud-based SaaS/PaaS platform for multi-omics data analysis, unifying secure sample management, interactive visual analysis, and a data lake for similarity searches and drug repurposing. The platform supports both no-code point-and-click analysis for biologists and code-based environments (JupyterLab/RStudio) for bioinformaticians, integrating transcriptomics (microarray, bulk RNA-seq, scRNA-seq) and proteomics data with role-based access control and audit logging for enterprise compliance.
Is Panomics a public or private company?
Panomics is a private company. It is classified as corporate owned and is currently operating.
When was Panomics founded?
Panomics was founded in 2022. It employs 1 to 10 people.
Where is Panomics based?
Panomics is headquartered in New York, United States, in the North America region.
How does Panomics make money?
One revenue line is on record: saaS Platform Subscription.
Who are Panomics's main competitors?
Direct peers on record are DNAnexus, Lifebit, BC Platforms, Velsera (Seven Bridges) and SOPHiA Genetics. TetraScience is listed as an others. Broad incumbents are Dotmatics and Illumina (Illumina Connected Analytics). Emerging players are Genestack and Form Bio.
Does Panomics have an API?
Yes. Panomics provides API Keys functionality for programmatic access to the platform. Users can generate and manage API keys through the platform's API Keys documentation section (https://documentation.panomics.bio/documentation/api-keys). The API enables developers to build custom integrations and automate workflows within the Panomics platform. Developer documentation is at documentation.panomics.bio/documentation/api-keys.
What industry is Panomics in?
Panomics's product category is Bioinformatics / Multi-omics Analysis Software. Its primary akta.pro industry code is HLAGAJAD, Bioinformatics & Multi-omics Analysis Software, with a secondary code of HLAGANAI, Bioinformatics, Multi-Omics Data Analysis & Interpretation Services. Its NAICS code is 541714 and its SIC code is 7372.